Micreos
PrivateLast Round
Early Funding
Oct 25, 2022
Total Funding Raised
$108.94M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Micreos is a biotechnology company that discovers and develops recombinant proteins for chronic dermatology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, D2C Brands, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Micreos Comparables
Compare Micreos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GangaGen | 77% | |
| Lysando AG | 77% | |
| Intralytix, Inc. | 77% | |
Micreos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 25, 2022 | ||||
| Early Funding | Sep 30, 2021 | ||||
| Early Funding | Mar 29, 2019 | ||||
| Early Funding | Feb 18, 2016 | ||||
| Strategic | May 23, 2012 |
Key People
Founding team and executive leadership
Micreos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altria Ventures | Strategic |
| Ministry of Economic Affairs and Climate Policy of The Netherlands | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 916% MoM, from 642 to 6.5K.
- Jul 20, 2026
Open roles increased from 0 to 83, representing 415% of headcount.
Micreos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Micreos's valuation, stock price, and market status.